Building the Translational Evidence for Nurr1 Activation in Multiple Sclerosis from Preclinical Discovery to Clinical Biomarkers

3:30 pm - Wednesday 2nd December 2026

Speakers:

Amelie Schreieck
Senior Manager - Biomarker Development
Immunic Therapeutics